B-cell chronic lymphocytic leukemia (B-CLL ... Drugs that specifically inhibit BCR signaling elements are currently being tested in clinical trials. The promising results obtained so far suggest ...
The pathogenesis of some primary humoral immunodeficiencies with the presence of circulating B cells remains unknown and frequently causes diagnostic difficulties. Common variable immunodeficiency ...
Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today ...